CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that on June 28, 2019 the United States District Judge for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) issued a Final Judgment in favor of RMS Medical in the Company’s previously announced litigation with EMED Technologies (“EMED”) before that court. The District Judge adopted the decision of the Magistrate Judge that was issued on June 24, 2019, overruled EMED’s objections, awarded court costs to RMS Medical, and dismissed the case. This case was one of several pending between RMS Medical and EMED.
About RMS Medical Products
RMS Medical develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information about RMS Medical, please visit.
